The Difference in Serum Ferritin and Leukocyte Regarding Overweight and Obese South Korean Adults

한국 성인의 비만과 과체중에 따른 혈청 페리틴과 백혈구의 차이

Article information

J Korean Biol Nurs Sci. 2019;21(2):108-113
Department of Nursing, College of Life Science and Nano Technology, Hannam University, Daejeon, Korea
이혜순
한남대학교 간호학과
Corresponding author: Lee, Hea Shoon, Department of Nursing, College of Life Science and Nano Technology, Hannam University 70, Hannam-ro, Daedeok-gu, Daejeon 34430, Republic of Korea +82-42-629-8474 +82-42-629-8883 lhs7878@hanmail.net
*이 연구는 2019년 한남대학교 연구 기금에서 지원받았습니다.
*This work was supported by 2019 Hannam University Research Fund.
Received 2018 December 30; Revised 2019 February 26; Accepted 2019 February 27.

Abstract

Purpose: The purpose of this study was to investigate the difference in serum ferritin and leukocyte regarding overweight and obese South Korean adults. Methods: This study was conducted on 5,281 subjects older than 19, according to data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-3), 2015. Data were analyzed using descriptive statistics, t-test, ANOVA, Scheffe’s test, Pearson’s correlation coefficient, and stepwise multiple regression analysis (SPSS 24.0). Results: First, serum ferritin and leukocyte were higher regardubg obesity, followed by being overweight and within normal weight. Second, body mass index (BMI) was positively correlated with serum ferritin and leukocyte. Third, factors affecting serum ferritin were gender, and being obese and overweight. Explanatory power of the model was 26.2%. Factors affecting leukocyte were gender, obesity, being overweight, and weight change over the past year (weight gain). Explanatory power of the model was 10.2%. Conclusion: Obesity and being overweight were factors affecting serum ferritin and leukocyte, and obesity was more affected than being overweight in Koreans older than 19. In conclusion, serum ferritin was a marker of inflammation, rather than iron status, in overweight and obese Korean adults.

Introduction

Obesity is a global health problem, In 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these over 650 million were obese [1]. The obesity is classified as a “disease” in 2013 by the American Medical Association [2]. Obesity and overweight people persist in sub clinical inflammation, leading to of iron deficiency (ID) and iron deficiency anemia (IDA), malignancy, and so forth [3]. Serum ferritin is used as a marker of iron deficiency [4]. Serum ferritin levels are present in abnormal conditions because they are acute phase reactants, serum ferritin levels are high in overweight and obesity, which are generalized inflammatory conditions [5]. For this reason, the use of serum ferritin as a marker of ID or IDA in overweight or obese is controversial [6].

The inflammation caused by the increase of the adiposity will be suggested as a link between iron status and obesity [7]. Among the many metabolic activities of obesity, high Body mass index (BMI) is associated with incompatibility of iron parameters [8]. Chronic inflammation caused by obesity led to low iron status and showed low iron status in 38.8% of obesity and 12.1% of overweight [9]. Physical activity and weight gain are inversely related, thus, physical activity may reduce body iron deficiency in obesity [10].

When ID/IDA and obesity coexist, they double the adverse health effects of obesity itself. Chronic inflammation caused by excessive fat tissue, rather than diet, provides an explanation for obesity’s ID/IDA, but the presence of acute and chronic infections should also be considered and inflammatory diseases should be considered [11]. As a result, ferritin is an indicator of inflammation in overweight and obesity than iron status. Higher ferritin levels secondary to asymptomatic inflammation of overweight and obese people can conceal iron deficiency because they are acute-phase responders [12].

In a study of Korean adults, serum ferritin is a positive associated with metabolically obese normal weight [6], and serum ferritin is the highest in obesity and lowest in normal weight [12]. Serum ferritin levels are associated with incidence of obesity in Korean men [13] and had a positive correlation with BMI and negative correlation with iron [12].

On the other hand, obesity is associated with decreased anemia, high hemoglobin and platelets [14,15]. Platelets are correlated with body fat mass and body fat percentage, and chronic inflammation is the cause of platelet activation [15].

The leukocyte is a hematological parameter that could provide useful information about health condition, leukocyte is needed to protect against invading organisms and the immune system [16]. There is strong evidence for a link between obesity and increased leukocyte [17]. Also, serum ferritin is positive correlated with C-reactive protein (CRP) as an indicator of inflammation [12].

In previous studies, there is a difference in serum ferritin and leukocyte according to obesity level of foreigners [10,17], but there are few studies of obesity in Korea. In particular, studies investigating the difference in serum ferritin and leukocyte in overweight and obese groups are rare. Also, the effects of obesity have shown contradictory results for iron reduction [3,7-9] or iron gain [14,15]. Serum ferritin, which reflects iron status, is used as a variable in this study.

The Fifth Korea National Health and Nutrition Examination Survey is representative of nationwide survey data. Therefore, it is appropriate sample data to construct domestic reference value. In this study, we suggested a fundamental data of adult obesity prevention and management program by identifying the difference in serum ferritin and leukocyte according to overweight and obesity in Korean adults. We suggested a fundamental data of Korean adult obesity prevention and management program.

Methods

1. Research design

This study is a descriptive survey study which attends a secondary analysis of The Fifth Korea National Health and Nutrition Examination Survey’s raw data to investigate the difference in serum ferritin and leukocyte according to overweight and obesity in South Korean adults.

2. Samples and setting

Subject of this study is adult (over 19 years) and data was based on ‘The Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-3), 2015’ which Ministry of Health and Welfare and Korea Centers for Disease Control and Prevention conducted.

According to classification standard of BMI groups were divided in normal weight 2,303 (43.6%), overweight 1,282 (24.3%) and obesity 1,696 (32.1%). The total 5,281 subjects were analyzed as the data of this study.

3. Instruments

1) BMI

The subject’s height and weight were measured after overnight fasting with participants shoe less and wearing a lightweight gown. World Health Organization (WHO) classified BMI over 25 kg/m2 as overweight and over 30 kg/m2 as obesity [1]. However, it was not appropriate to apply it to Asians because it was developed based on the results of research on westerner [18]. In the World Health Organization Western Pacific region [19], classified BMI as normal weight less than 23 kg/m2, overweight as 23-24.9 kg/m2 and obesity as 25 kg/m2 or more. This criterion was applied in this study as well.

2) Blood measurement

Blood sampling was collected in the morning after fasting for 8 hours or more, and median cubital vein was punctured using a vacutainer needle and blood was drawn into a vacuum tube.

Serum ferritin was measured by immuno-radiometric assay using a 1470 Wizard Gamma Counter (Perkin-Elmer, Finland). Leukocyte was measured by laserflow cytometry using a Sysmex XE2100D (Sysmex, Japan).

4. Ethical consideration

The Korea National Health and Nutrition Examination Survey which was used in this study was reviewed from Korea Centers for Disease Control and Prevention Institutional Review Boards (IRB)(2012-01EXP-01-2C), and subject’s anonymity and confidentiality were guaranteed by collecting their private information in serial number which was unable to distinguish, and we conducted an annual survey. In this study, according to the raw data open and care regulation of Korea Centers for Disease Control and Prevention, after the researcher got confirmation for using data (Dec 7th, 2017), the data was provided, and we used them.

5. Data analysis

The data was analyzed by SPSS WIN 24.0 program (SPSS Inc. Chicago, IL, USA). The general characteristic of subject was analyzed by descriptive statistics. Difference of serum ferritin and leukocyte depends on subject’s obesity degree was analyzed by t-test, ANOVA, Scheffe’s test, Correlation among subject’s BMI, serum ferritin and leukocyte were analyzed by Pearson correlation coefficient. The predictive variables for serum ferritin and leukocyte were analyzed by stepwise multiple regression. All significance were analyzed using a 2-tailed method, and a P-value<0.05 was considered statistically significant.

Results

1. General characteristics of subject

The average age of the subjects were 50.80 years old. The average BMI was 23.76 kg/m2, specifically, normal weight was 43.6%, overweight was 24.3%, and obesity was 32.1%. The average serum ferritin was 81.88 (ng/mL) and the average leukocyte was 5.87 (x103/uL) (Table 1).

General Characteristics of Subject (N=5,281)

2. Differences of serum ferritin and leukocyte according to subject’s BMI

The serum ferritin was higher in males than females (t=38.69, p<.001). According to BMI classification, serum ferritin was highest in obesity, followed by overweight and normal weight (F=181.15, p<.001). The leukocyte was higher in males than in females (t=15.27, p<.001). In weight change over the past year, weight gain was higher than no change (within 0-3 kg) and weight loss (F=9.06, p<.001). According to the BMI classification, leukocyte was the highest in obesity, followed by overweight and normal weight (F=76.82, p<.001) (Table 2).

Differences of Serum ferritin and Leukocyte according to Subject's BMI (N=5,281)

3. Correlation among subject’s BMI, serum ferritin and leukocyte

The subject’s BMI was positively correlated with serum ferritin (r=0.20, p<.001) and leukocyte (r=0.17, p<.001) (Table 3).

Correlation among Subject's BMI, Serum ferritin and Leukocyte (N=5,281)

4. Predictive variables for serum ferritin and leukocyte

To determine the factors affecting serum ferritin and leukocyte, gender, weight change over the past year and BMI (obesity, overweight, normal weight), which showed significant differences in serum ferritin and leukocyte were regarded as independent variables. A stepwise multiple regression analysis was performed and the nominal scale was converted to a dummy variable.

Serum ferritin regression model was significant (F=468.55, p<.001) and the explanatory power of the model was 26.2%. Factors affecting serum ferritin were gender (female) (β=-.455, p<.001), obesity (β=.209, p<.001), and overweight (β=.075, p<.001).

The leukocyte regression model was significant (F=36.42, p<.001) and the explanatory power of the model was 10.2%. Factors affecting leukocyte was gender (female) (β=-.191, p<.001), obesity (β=.149, p<.001), overweight (β=.060, p<.001), and weight change over the past year (weight gain) (β=.047, p=.001) (Table 4).

Predictive Variables for Serum ferritin and Leukocyte (N=5,281)

Discussion

The study is performed to investigate the difference in serum ferritin and leukocyte according to overweight and obesity in South Korean adults. In this study, BMI and serum ferritin are positive correlation, and serum ferritin is the highest in obesity, followed by overweight and normal weight. In addition, factors affecting serum ferritin is gender, obesity, and overweight.

The study second, third and fourth quartiles of serum ferritin levels are incident obesity 1.08 times, 1.14 times, and 1.24 times as compared with the first quartile, also there is a consistent association with severe obesity (BMI≥30 kg/m2) [13]. Serum ferritin is a marker of inflammation in obese subjects, the high BMI is to have a high level of serum ferritin, which can be caused because of the dominant inflammatory conditions, in the presence of an increased adipose tissue [12]. Increased body fat tissue appears to be associated with an increased risk of iron deficiency that can be masked by elevated serum ferritin levels, perhaps the increased cytokines results in increased acute phase reactant synthesis leading to a decrease in macrophages sequestration and / or intestinal iron uptake [20].

The expression of serum ferritin, a prime indicator of iron status, is stimulated by a number of factors, including cytokines released during inflammation and liver disease. Inflammation in turn leads to hepatic synthesis of acute-phase proteins and obesity is one of the most common and prevalent conditions promoting low-level inflammation [21]. ID commonly observed in overweight and obese people is most likely due to inflammatory mechanisms [22].

IDA occurs most often due to malnutrition. Obesity, on the other hand, is often caused by excessive nutrition. Therefore, the coexistence of IDA and obesity in the same person indicates malnutrition and hyper nutrition. Among the factors responsible for mutual co-existence, such as diluted hypoferremia, lack of dietary iron intake, increased iron demand, and/or iron absorption disorder, hepcidin has recently been identified as a major cause of obesity ID or IDA [23].

In this study, BMI and leukocyte were positive correlation, and leukocyte was the highest in obesity, followed by overweight and normal weight. In addition, factors affecting leukocyte were gender, obesity, overweight and weight change over the past year (weight gain). The study found a positive correlation between BMI and leukocyte in the obese group [24] and cross-sectional studies reported a positive association between obesity and leukocyte count [17]. The number of leukocyte in overweight and obesity was 1.06 times (95% CI=0.9-1.2) and 1.11 times (95% CI=0.9-1.3), respectively [14]. A previous study showed some factors that cause continuous increase in leukocyte in obese patients [25]. Obesity is the only identified cause in patients with leukopenia. In another study, people with central fat had higher levels of some inflammatory markers, including leukocyte counts, 17% higher than those with normal body fat distribution [26]. Leukocytes increased with increasing waist circumference(WC), and the number of leukocytes are the most consistent between BMI and WC [25].

It has been shown that there is some association between increased numbers of immune cells and obesity as a result of chronic inflammatory conditions resulting from increased cytokines production by adipose tissue, obesity has also been demonstrated to be associated with low-grade sub clinical and smoldering inflammation [27], supporting the results of this study. The previous findings are positive correlation between cell number and obesity have been reported in cross-over study [16]. Measurements of central fat accumulation have been found to be more closely related to the various diseases and health conditions of BMI in both gender [25]. It is necessary to study the difference of serum ferritin and leukocyte including WC and BMI.

The sampling framework of the National Health and Nutrition Survey used in this study was designed to extract representative samples. So, the results of this study, it was meaningful that it can represent the characteristics of Korean adults.

As a limitation of this study, the increase of leukocyte in obesity may be due to hypervolemic in obese people, resulting in a naturally increasing number of blood cells. In addition, the correlation between obesity and chronic inflammation requires implementation of not only leukocyte but also inflammatory markers (for example, CRP).

Conclusions

In this study, obesity and overweight is a factor affecting serum ferritin and leukocyte, and obesity is more affected than overweight in Korean aged over 19 years. In conclusion, Serum ferritin is a marker of inflammation rather than iron status in overweight and obese Korean adults. Because of acute-phase reactions, high ferritin levels secondary to asymptomatic inflammation of both overweight and obesity can mask underlying iron deficiency. It is recommended to request an iron studies including transferrin saturation, total iron binding capacity, and the like.

CONFLICT OF INTEREST

The authors declared no conflict of interest.

References

1. World Health Organization. Obesity and Overweight [Internet] 2017. Geneva: World Health Organization; [cited 2019 March 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Kelly F.. Obesity Is Now A Disease, American Medical Association Decides[internet] 2013. Brighton: Healthline Media UK Ltd. [cited 2018 May 10]. Available from: https://www.medicalnewstoday.com/articles/262226.php.
3. Kohlgruber A.L., Lynch L.. Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Current Diabetes Reports 2015;15(11):92. http://dx.doi.org/10.1007/s11892-015-0670-x.
4. Bansal P.G., Toteja G.S., Bhatia N., Vikram N.K., Siddhu A., Garg A.K., et al. Deficiencies of serum ferritin and vitamin B12, but not folate, are common in adolescent girls residing in a slum in Delhi. International Journal for Vitamin and Nutrition Research 2015;85(1-2):14–22. http://dx.doi.org/10.1024/0300-9831/a000219.
5. O’Brien H.T., Blanchet R., Gagn´e D., Lauzi`ere J., V´ezina C.. Using soluble transferrin receptor and taking inflammation into account when defining serum ferritin cutoffs improved the diagnosis of iron deficiency in a group of Canadian preschool Inuit children from Nunavik. Anemia 2016;Article ID 6430214. https://doi.org/10.1155/2016/6430214.
6. Kim J.W., Kim D.H., Roh Y.K., Ju S.Y., Nam H.Y., Nam G.E., et al. Serum ferritin levels are positively associated with metabolically obese normal weight: a nationwide population-based study. Medicine 2015;94(52)Article ID e2335. http://dx.doi.org/10.1097/MD.0000000000002335.
7. McClung J.P., Andersen N.E., Tarr T.N., Stahl C.H., Young A.J.. Physical activity prevents augmented body fat accretion in moderately iron-deficient rats. The Journal of Nutrition 2008;138(7):1293–1297. http://dx.doi.org/10.1093/jn/138.7.1293.
8. Cheng H.L., Bryant C., Cook R., O’Connor H., Rooney K., Steinbeck K.. The relationship between obesity and hypoferraemia in adults: A systematic review. Obesity Reviews 2012;13(2):150–161. http://dx.doi.org/10.1111/j.1467-789X.2011.00938.x.
9. Pinhas-Hamiel O., Newfield R.S., Koren I., Agmon A., Lilos P., Phillip M.. Greater prevalence of iron deficiency in overweight and obese children and adolescents. International Journal of Obesity 2003;27(3):416–418. http://dx.doi.org/10.1038/sj.ijo.0802224.
10. Lecube A., Carrera A., Losada E., Hernández C., Simó R., Mesa J.. Iron deficiency in obese postmenopausal women. Obesity 2006;14(10):1724–1730. http://dx.doi.org/10.1038/oby.2006.198.
11. Jericó C, Bretón I, García Ruiz de GA, de Oliveira AC, Rubio MÁ, Tinahones FJ, et al. Diagnosis and treatment of iron deficiency, with or without anemia, before and after bariatric surgery. Endocrinologíay nutrición 2016;63(1):32–42. https://doi.org/10.1016/j.endonu.2015.09.003.
12. Khan A., Khan W.M., Ayub M., Humayun M., Haroon M.. Ferritin Is a Marker of Inflammation rather than Iron Deficiency in Overweight and Obese People. Journal of Obesity 2016;Article ID 1937320. http://dx.doi.org/10.1155/2016/1937320.
13. Park S.K., Choi W.J., Oh C.M., Kim J.E., Shin H.H., Ryoo J.H.. Association between serum ferritin levels and the incidence of obesity in Korean men: A prospective cohort study. Endocrine Journal 2014;61(3):215–224. http://dx.doi.org/10.1507/endocrj.EJ13-0173.
14. Abdelmageed E., Duria A.R., Renda E., Abdelmageed I.A., Gasim I.G.. High level of hemoglobin, white blood cells and obesity among Sudanese women in early pregnancy: a cross-sectional study. Future science OA 2017;3(2)FSO182. http://dx.doi.org/10.4155/fsoa-2016-0096.
15. Zhang S.Z., Jin Y.P., Qin G.M.. Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-ST elevation acute coronary syndromes. Clinical cardiology 2007;30(1):26–31. http://dx.doi.org/10.1002/clc.2.
16. Imano H., Sato S., Kitamura A., Kiyama M., Ohira T., Shimamoto T., et al. Leukocyte count is an independent predictor for risk of acute myocardial infarction in middle-aged Japanese men. Atherosclerosis 2007;195(1):147–152. http://dx.doi.org/10.1016/j.atherosclerosis.2006.09.002.
17. Dixon J.B., O’Brien P.E.. Obesity and the white blood cell count: changes with sustained weight loss. Obesity Surgery 2006;16(3):251–257. http://dx.doi.org/10.1381/096089206776116453.
18. Sim K.W., Lee S.H., Lee H.S.. The relationship body mass index and morbidity in Korea. Journal of Korean Society for the Study of Obesity 2001;10(2):147–155.
19. World Health Organization Western Pacific Region. The Asia-pacific perspective: Redefining obesity and its Treatment 2000. Australia: WHO Western Pacific Region.
20. Cepeda-Lopez A.C., Aeberli I., Zimmermann M.B.. Does obesity increase risk for iron deficiency? a review of the literature and the potential mechanisms. International Journal for Vitamin and Nutrition Research 2010;80(45):263–270. http://dx.doi.org/10.1024/0300-9831/a000033.
21. Shiwaku K., Anuurad E., Enkhmaa B., Kitajima K., Yamane Y.. Appropriate BMI for Asian populations. The Lancet 2004;363(1077):157–163. http://dx.doi.org/10.1016/S0140-6736(04)15856-X.
22. Lecube A., Hern´andez C., Pelegr´ı D., Sim´o R.. Factors accounting for high ferritin levels in obesity. International Journal of Obesity 2008;32(11):1665–1669. http://dx.doi.org/10.1038/ijo.2008.154.
23. Villarroel H.P., Arredondo O.M., Olivares G.M.. Hepcidin as a central mediator of anemia of chronic diseases associated with obesity. Revista Medica de Chile 2013;141(7):887–894. http://dx.doi.org/10.4067/S0034-98872013000700008.
24. Jamshidi L., Sief A.. Association Between Obesity, White Blood Cell and Platelet Count. Zahedan Journal of Research in Medical Sciences 2017;9(2)e4955. http://dx.doi.org/10.5812/zjrms.4955.
25. Herishanu Y., Rogowski O., Polliack A.. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. European Journal of Haematology 2006;76(6):516–520. http://dx.doi.org/10.1111/j.1600-0609.2006.00658.x.
26. Panagiotakos D.B., Pitsavos C., Yannakoulia M., Chrysohoou C., Stefanadis C.. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005;183(2):308–315. http://dx.doi.org/10.1016/j.atherosclerosis.2005.03.010.
27. Samocha-Bonet D., Justo D., Rogowski O., Saar N., Abu-Abeid S., Shenkerman G., et al. Platelet counts and platelet activation markers in obese subjects. Mediators Inflammation 2008;:6. Article ID 834153: https://doi.org/10.1155/2008/834153.

Article information Continued

Table 1.

General Characteristics of Subject (N=5,281)

Variables Category Mean±SD n (%) Acquired score range

Age (years) 50.80±16.39 19-88
Gender Male 2219 (42.0)
Female 3062 (58.0)
Education level Under elementary school 1314 (24.9)
Middle School 565 (10.7)
High school 1787 (33.9)
Above college 1607 (30.5)
Weight change over the past year No change (within 0-3Kg) 3568 (67.6)
Weight loss 747 (14.1)
Weight gain 966 (18.3)
BMI (kg/m2) 23.76±3.40 14.42-53.54
Normal weight (<23) 2303 (43.6)
Overweigh (23-24.9) 1282 (24.3)
Obese (≥25) 1696 (32.1)
Serum ferritin (ng/mL) 81.88±48.23 12.00-450.40
leukocyte (×103/uL) 5.87±1.65 2.00-24.00

SD=Standard deviation; BMI=Body mass index.

Table 2.

Differences of Serum ferritin and Leukocyte according to Subject's BMI (N=5,281)

Variables Category Serum ferritin Leukocyte


Mean±SD t/ F (p-value) Mean±SD t/ F (p-value)

Gender Male 122.71±52.83 38.69 (<.001) 6.27±1.68 15.27 (<.001)
Female 49.84±28.45 5.58±1.55
Education level Under elementary school1 78.47±25.07 2.26 (.105) 5.80±1.72 1.53 (.203)
Middle School2 81.61±38.60 5.91±1.64
High school3 77.45±37.98 5.92±1.59
Above college4 81.14±36.51 5.86±1.63
Weight change over the past year No change (within 0-3Kg)1 80.31±25.75 0.97 (.378) 5.81±1.60 9.06 (<.001)
Weight loss2 83.53±21.63 5.90±1.76
Weight gain3 78.32±32.60 6.06±1.69 1,2<3
BMI (kg/m2) Normal weight (<23)1 60.50±24.30 181.15 (<.001) 5.59±1.62 76.82 (<.001)
Overweigh (23-24.9)2 82.94±38.22 5.90±1.53
Obese (≥25)3 105.46±47.67 1<2<3 6.23±1.68 1<2<3

SD=Standard deviation; BMI=Body mass index.

Table 3.

Correlation among Subject's BMI, Serum ferritin and Leukocyte (N=5,281)

Variables BMI Serum ferritin Leukocyte

r (p value)

BMI 1
Serum ferritin 0.20 (<.001) 1
Leukocyte 0.17 (<.001) 0.14 (<.001) 1

BMI=Body mass index.

Table 4.

Predictive Variables for Serum ferritin and Leukocyte (N=5,281)

Variables Serum ferritin Leukocyte


β t p β t p

Gender (female) -.455 -37.55 <.001 -.191 -14.19 <.001
BMI (kg/m2)
Obesity (≥25) .209 16.01 <.001 .149 1.12 <.001
Overweigh (23-24.9) .075 5.78 <.001 .06 4.15 <.001
Weight change over the past year (weight gain) .047 3.46 .001
Constant 42.242 <.001 73.587 <.001
Adjusted R2 .262 .102
F (p) 468.55 (<.001) 36.42 (<.001)

BMI=Body mass index.